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OBJECTIVES We evaluated whether patients’ clinical status, angioplasty success, or both, should guide
discharge after primary angioplasty (i.e., percutaneous coronary intervention [PCI]) for acute
myocardial infarction (AMI).
BACKGROUND Current guidelines do not address a discharge strategy for AMI patients undergoing
successful PCI.
METHODS Patients who underwent PCI in Primary Angioplasty in Myocardial Infarction (PAMI)
studies (N  3,188) were classified as “high clinical risk” if they had either age 70 years,
Killip class 1, heart rate 100 beats/min, systolic blood pressure 100 mm Hg, anterior
MI, or left bundle branch block, and as “low clinical risk” if none was present. Successful PCI
patients were compared with those with unsuccessful PCI in both groups for 30-day major
adverse cardiac events (MACE).
RESULTS Percutaneous coronary intervention was successful in 668 (90%) of 745 low-risk clinical and
2,104 (86%) of 2,443 high-risk clinical patients. Regardless of clinical risk status, patients
with successful PCI had lower 30-day MACE than those with unsuccessful PCI (low-risk
group: 4.6% vs. 22%, p  0.0001; high-risk group: 7% vs. 21%; p  0.0001). Moreover,
successful PCI patients with either risk status had few MACE after day 4, whereas
unsuccessful PCI patients had more MACE. The success of PCI was the strongest
independent predictor of 30-day MACE (odds ratio [OR] 3.7, 95% confidence interval [CI]
2.8 to 5.0). A constellation of three or more high-risk clinical features also predicted higher
30-day MACE (OR 2.25, 95% CI 1.62 to 3.12).
CONCLUSIONS The success of PCI is the prime determinant of clinical outcome after PCI for AMI. The
majority of AMI patients with less than three high-risk clinical features who undergo
successful PCI may be discharged from the hospital by day 4. In contrast, patients with more
than two high-risk clinical features or unsuccessful PCI may need longer observation. (J Am
Coll Cardiol 2004;44:1400–7) © 2004 by the American College of Cardiology Foundationo
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Aith current emphasis on evidence-based medicine and
ost effectiveness, the timing of discharge of acute myocar-
ial infarction (AMI) patients from the hospital is crucially
mportant. Practice guidelines for management of AMI
ecommend a predischarge submaximal stress electrocardio-
ram or some form of pharmacologic stress imaging at four
o six days (1) and further invasive testing, if indicated,
efore discharge from the hospital. The value of routine four
o six days of monitoring and subsequent noninvasive
esting in patients with an uncomplicated course after
uccessful primary angioplasty for AMI is uncertain. It has
een shown that early identification of low-risk patients
ith MI results in safe omission of the intensive care phase
nd noninvasive testing, a day 3 hospital discharge strategy,
nd substantial cost savings (2).
In general, clinically low-risk AMI patients suffer few
ardiac events early after AMI. It is also well established
hat patients with AMI who undergo successful percutane-
From the *William Beaumont Hospital, Royal Oak, Michigan; †Guthrie Clinic,
ayre, Pennsylvania; ‡Lenox Hill Hospital, New York, New York; and §Duke
niversity Medical Center, Durham, North Carolina.
Manuscript received February 17, 2004; revised manuscript received June 17, 2004,sccepted June 22, 2004.us coronary intervention (PCI) fare much better than those
ho fail to reperfuse (3). Although angiographic success and
low-risk status” are both associated with better outcomes, a
iven patient may fall into one group, both groups, or
either group. Currently, patients with a low clinical risk
tatus are often selected for early discharge, whereas high-
isk patients are observed for a longer period, regardless of
CI success. However, it is unclear whether PCI success
nfluences outcomes differently among the two risk catego-
ies or provides guidance for discharge planning.
The purpose of this analysis was to determine the
mportance of PCI success among the two clinical risk
roups in identifying patients who could be discharged from
he hospital early.
ETHODS
atient selection. The Primary Angioplasty in Myocardial
nfarction (PAMI) studies prospectively enrolled 4,023
atients with AMI in seven different trials (PAMI-1,
AMI-2, PAMI Stent Pilot, Stent PAMI, Local PAMI,
ir PAMI, and PAMI-No SOS) (2,4–10), including twotudies with concomitant registry enrollment (5,8). The
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October 6, 2004:1400–7 Discharge Strategy After Primary Angioplastynclusion and exclusion criteria for these trials are published
lsewhere (11). In all of the PAMI trials, patients were18
ears old, had ST-segment elevation of 1 mm in two or
ore contiguous leads and/or left bundle branch block, and
ymptom onset within 12 h. Patients were excluded if
hrombolytic agents were given for the index ST-segment
levation myocardial infarction (MI), were in cardiogenic
hock, had a stroke within a month, were of child-bearing
otential, had end-stage renal disease, or a life expectancy
rom a noncardiac condition of 1 year. Of the 4,023
atients enrolled in PAMI trials, 3,188 who underwent PCI
nd had a record of final Thrombolysis In Myocardial
nfarction (TIMI) flow grade and final diameter stenosis
ere included in this analysis.
ata collection and comparisons. For each of the clini-
al trials, research nurses or coordinators at each site
ollected data prospectively and completed detailed case-
eport forms. Independent data monitors traveled to the
articipating sites to verify hospital records for all pa-
ients. Cine angiograms, which were obtained at the time
f the acute coronary intervention, were analyzed by the
ndividual operators and subsequently by core laborato-
ies to assess coronary anatomy and estimate TIMI flow
rades, percentage diameter stenosis, left ventricular
jection fraction (LVEF), and angiographic outcomes of
ntervention.
We pooled the clinical, demographic, angiographic, and
utcomes data on the 3,188 patients included in this
nalysis. Patients were considered to be high risk if they had
ny of the following: age 70 years, heart rate 100
eats/min, systolic blood pressure 100 mm Hg, Killip
lass 1, anterior MI, or left bundle branch block (LBBB).
hese clinical features were used to define high-risk patients
n the Air-PAMI study (10) and have been previously
hown to be the most important predictors of early outcome
fter AMI (12). Success of PCI was determined by a
iameter stenosis 30% and TIMI flow grade 3 on final
ngiography. Core laboratory data were used in most
nalyses. Core laboratory data were considered incomplete
or LVEF and initial TIMI flow grade; therefore, operator-
efined data were used for these variables.
For the purpose of this analysis, patients were classified
nto four groups based on the technical success of PCI and
he clinical risk status: group 1  clinical low-risk and
Abbreviations and Acronyms
AMI  acute myocardial infarction
I-TVR  ischemia-driven target vessel revascularization
LBBB  left bundle branch block
LVEF  left ventricular ejection fraction
MACE major adverse cardiac events
PAMI  Primary Angioplasty in Myocardial Infarction
PCI  percutaneous coronary intervention
TIMI  Thrombolysis In Myocardial Infarctionuccessful PCI; group 2  clinical high-risk and successful gCI; group 3  clinical low-risk and unsuccessful PCI; and
roup 4  clinical high-risk and unsuccessful PCI. We
ompared baseline clinical, demographic, and angiographic
haracteristics between these four groups. We also com-
ared in-hospital and 30-day outcomes (death, re-
nfarction, or ischemia-driven target vessel revascularization
I-TVR]) between the groups.
tudy end points and definitions. The primary study
utcomes included in-hospital mortality and in-hospital and
0-day incidence of major adverse cardiac events (MACE),
efined as death, re-infarction, or I-TVR. Re-infarction was
efined as recurrent clinical symptoms or the development
f new electrocardiographic changes accompanied by new
levation of creatine kinase and creatine kinase-MB enzyme
evels. Ischemia-driven TVR was defined as TVR prompted
y symptoms or objective evidence of ischemia. The inci-
ences of in-hospital complications, such as bradycardia,
entricular arrhythmia, sustained hypotension, cardiopul-
onary resuscitation, disabling stroke, and the need for
nitiation of hemodialysis, were also compared between the
our groups. Sustained hypotension was defined as systolic
lood pressure 80 mm Hg unresponsive to intravenous
uids, requiring pressors for 1 h or intra-aortic balloon
ump.
tatistical analysis. Statistical analyses were completed on
he categorical variables using the chi-square test when
ppropriate (expected frequency 5). Otherwise, the Fisher
xact test was used. Continuous variables were analyzed
sing a nonparametric two-tailed Wilcoxon rank test. Step-
own multivariate logistic regression was utilized to adjust
or baseline differences in clinical and angiographic charac-
eristics, as well as technical success of PCI to derive
ndependent predictors of death, re-infarction, and MACE.
aplan-Meier curves were analyzed using the log-rank test
omparing the four categories. All analyses were completed
sing SAS version 8.0 (SAS Institute, Cary, North
arolina).
ESULTS
ercutaneous transluminal intervention was successful in
,772 patients (87%), and 2,443 (77%) had at least one
igh-risk clinical feature. Among the clinical high-risk
atients, 1,368 (39.4%) had one risk factor, whereas two,
hree, four, and five risk factors were present in 816 (23.5%),
33 (9.6%), 96 (2.8%), and 16 (0.5%) patients, respectively.
ge 70 years was seen in 844 (24.7%), heart rate 100
eats/min in 665 (19.5%), systolic blood pressure100 mm
g in 973 (28.5%), Killip class 1 in 448 (13.1%), anterior
I in 1,433 (42%), and LBBB in 36 (1%) patients. Baseline
linical characteristics in each of the four subgroups are
iven in Table 1. Patients with unsuccessful PCI more often
ad diabetes and previous coronary artery bypass grafting
han those who had successful PCI. The high-clinical risk
roup was older and had more females, a higher Killip class,
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Discharge Strategy After Primary Angioplasty October 6, 2004:1400–7nd more often a history of congestive heart failure, as
ompared with the low-risk group.
Baseline angiographic data is given in Table 2. Patients
ith unsuccessful PCI had a longer chest pain onset to
alloon time. They also had a higher prevalence of mul-
ivessel disease, TIMI flow grade 0 or 1 in the infarct-
elated artery on the initial angiogram, and a higher prev-
lence of thrombus at the culprit site. The incidence of
issection was more frequent in patients with unsuccessful
CI than in those with successful PCI. The high-clinical
isk group had a lower LVEF and, by definition, had a left
able 1. Baseline Characteristics of the Patients
Variables
Low Clinical Risk
Successful PCI
(n  668)
Failed PCI
(n  77) V
ge (yrs, mean  SD) 55 9 58 8 0
emales (%) 21 18 0
iabetes (%) 14 22 0
ypertension (%) 43 44 0
urrent smoker (%) 52 45 0
yperlipidemia (%) 44 48 0
revious MI (%) 14 18 0
revious CABG (%) 3.6 8.5 0
revious PTCA (%) 12 12 0
revious heart failure (%) 0.6 0 1
revious angina (%) 15 17 0
OPD (%) 3.0 2.9 1
revious CVA (%) 4.4 2.6 0
illip class (%)
1 100 100
2 0 0
3 0 0
4 0 0
Part of the definition for high clinical risk—therefore, no p value.
CABG  coronary artery bypass graft surgery; COPD  chronic obstructive pu
ercutaneous coronary intervention; PTCA  percutaneous transluminal coronary a
able 2. Angiographic Data
Variables
Low Clinical Risk
Successful PCI
(n  668)
Failed PCI
(n  77)
hest pain onset to balloon
inflation time (min)
269  148 (226) 334 233 (230)
jection fraction (%) 53  10 53  11
ultivessel disease (%) 48 52
nfarct artery (%)
RCA 69 74
LAD 0 0
LCx 29 22
Left Main 0 0
SVG or IMA 1.5 1.3
Unidentified 0.7 2.6
nitial TIMI flow grade 1 26 14
nitial percent stenosis 98 5 99  4
hrombus (%) 8.1 32 
issection (%) 14 38 
tent use (%) 43 13 
bciximab use (%) 3.2 14 
Part of the definition for high clinical risk—therefore, no p value. Data are present
IMA  internal mammary artery; LAD  left anterior descending coronary angioplasty; RCA  right coronary artery; SVG  saphenous vein graft; TIMI  Thromnterior descending coronary artery as the predominant
nfarct-related artery.
Data on postdischarge medical treatment were not avail-
ble, and the data on in-hospital medication use were
ncomplete. Analysis of the available information showed no
ignificant differences in the in-hospital use of aspirin, ticlid,
eta-blockers, or angiotensin-converting enzyme inhibitors
etween the groups of successful and failed PCI within the
linical low-risk group. Within the clinical high-risk group,
owever, patients with failed PCI received beta-blockers
ess often than those who had successful PCI did (57% vs.
High Clinical Risk
p Value Low
vs. High Risk
Successful PCI
(n  2,104)
Failed PCI
(n  339)
p
Value
62  13 64 12 0.0078 *
29 28 0.90 0.0001
16 23 0.0013 0.27
46 52 0.031 0.12
38 39 0.93 0.0001
39 35 0.24 0.013
13 18 0.044 0.67
3.6 7.6 0.0008 0.72
9 10 0.60 0.019
2.9 3.0 0.87 0.0002
16 20 0.11 0.66
4.5 9.4 0.0048 0.074
5.3 7.3 0.13 0.045
83.2 78.5 0.16 *
14 18.8
2.4 2.4
0.4 0.3
ry disease; CVA  cerebrovascular accident; MI  myocardial infarction; PCI 
asty.
High Clinical Risk
p Value Low
vs. High Risk
Successful PCI
(n  2,104)
Failed PCI
(n  339)
p
Value
290 187 (231) 305 172 (260) 0.005 0.045
47 12 45  13 0.002 0.0001
46 57 0.0002 0.62
34.5 31.0 * *
52 50 * *
9.5 9.7 * *
0.8 1.5 * *
0.6 2.4 * *
1.6 2.4 * *
25 17 0.001 0.36
98 4 98  6 0.007 0.44
1 7 28 0.0001 0.41
1 14 29 0.0001 0.40
1 42 19 0.0001 0.48
12 12 0.92 0.0001
he mean value  SD (median) or percentage of patients.
LCx  left circumflex artery; PCI  percutaneous coronary intervention/primaryp
alue
.017
.61
.07
.81
.25
.54
.33
.06
.90
.00
.68
.00
.76
*
lmonap
Value
0.12
0.80
0.55
*
*
*
*
*
*
0.021
0.023
0.000
0.000
0.000
0.001
ed as t
rtery;bolysis In Myocardial Infarction.
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October 6, 2004:1400–7 Discharge Strategy After Primary Angioplasty7%, p  0.0001). Information on beta-blocker use was
issing in 334 of the 2,443 high-risk patients. There was no
ifference in the in-hospital use of aspirin and angiotensin-
onverting enzyme inhibitors. No data were available on the
se of statins.
n-hospital clinical outcomes. Table 3 shows the in-
ospital complications and outcomes. In-hospital mortality
as highest in the high-risk group with unsuccessful PCI
10.9%) and lowest in the low-risk group with successful
CI (0.5%). The group with unsuccessful PCI had higher
n-hospital MACE than the group with successful PCI,
rrespective of their clinical risk status (16.9% vs. 3.7%, p 
.0001 in the low-risk group; 17.4% vs. 5.6%, p 0.0001 in
he high-risk group). This was primarily due to an increased
ate of recurrent MI and I-TVR. Sustained hypotension and
ntra-aortic balloon pump use was more frequent in patients
ho had unsuccessful PCI, irrespective of their risk status.
Step-down multivariate logistic regression analysis showed
hat unsuccessful PCI, advancing age, and multi-vessel disease
ere the only independent predictors of in-hospital death
Table 4). In-hospital MI was predicted by unsuccessful PCI
nd not using a stent. Other variables, including diabetes and
able 4. Multivariate Predictors of In-Hospital Outcome
OR 95% CI p Value
ACE
Unsuccessful PCI 3.36 2.45–4.60 0.0001
No stent 1.41 1.02–1.930 0.036
Age 1.04 1.02–1.05 0.0001
High clinical risk 1.05 0.72–1.54 0.79
eath
Unsuccessful PCI 4.57 2.95–7.10 0.0001
Multivessel disease 1.91 1.20–3.04 0.0061
Age 1.08 1.06–1.11 0.0001
High clinical risk 2.07 0.86–4.95 0.10
e-infarction
No stent 3.21 1.56–6.60 0.0015
PCI failure 2.36 1.33–4.17 0.0032
High clinical risk 1.47 0.74–2.92 0.27
I  confidence interval; MACE  major adverse cardiac events; OR  odds ratio;
able 3. In-Hospital Complications and Outcomes (%)
Variables
Low Risk
Successful PCI
(n  668)
Failed PCI
(n  77)
p
Valu
eath 0.5 3.9 0.0
e-infarction 0.9 5.2 0.0
-TVR 3.3 13.7 0.0
troke 0 0 —
ACE 3.7 16.9 0.0
se of IABP 5.3 15 0.0
ustained hypotension
VSD/MR
2.0 9.3 0.0
0 0 —
entricular arrhythmia 3.4 2.6 1.0
radyarrhythmia 1.1 2.6 0.2
ialysis 0 0 —
ABP  intra-aortic balloon pump; I-TVR  ischemia-driven target vessel revascu
ercutaneous coronary intervention; VSD  ventricular septal defect.rCI  percutaneous coronary intervention.bciximab use, did not predict in-hospital outcome. In-hospital
eta-blocker use was not an independent predictor of MACE
p  0.48). Clinical high-risk status was not an independent
redictor of either in-hospital death or re-infarction and
redicted a lower incidence of in-hospital TVR.
0-day clinical outcomes. Table 5 shows one-month clini-
al outcomes in different subgroups. Irrespective of their
linical risk status, patients with unsuccessful PCI had a higher
ncidence of death (9.8%), re-infarction (5.2%), and I-TVR
10.3%) at one month than those who had successful PCI.
atients with unsuccessful PCI had more MACE at one
onth (22% vs. 6%, p  0.0001), mostly attributable to a
ubstantially higher number of TVR in the low-risk group with
nsuccessful PCI (18% vs. 4%, p  0.0001) during the first
onth.
Multivariate logistic regression analysis once again showed
hat unsuccessful PCI, age, and multi-vessel disease were
trong predictors of both 30-day MACE and mortality (Table
). In addition, female gender emerged as an independent
redictor of 30-day mortality, whereas female gender as well as
ot using a stent independently predicted 30-day MACE. In
ontrast, clinical high-risk status was not an independent
redictor of higher 30-day MACE and showed only a trend
oward higher 30-day mortality. Other baseline variables,
ncluding a history of diabetes, hypertension, previous MI,
revious congestive heart failure, peripheral vascular disease,
nd previous coronary artery bypass graft surgery were not
ndependent predictors of either 30-day MACE or mortality.
Figure 1 shows Kaplan-Meier curves showing the cumu-
ative incidence of MACE (death, MI, and I-TVR) at 30
ays. Patients with successful PCI had very few MACE
fter hospital day 4, whereas patients with unsuccessful PCI
ontinued to experience MACE beyond the first four
ospital days at a much higher rate (2.5% vs. 6.7%, p 
.001). Figures 2 and 3 show Kaplan-Meier survival curves
or death and MI as well as death at 30 days, respectively.
nce again, the group with successful PCI had a low event
High Risk
p Value Low
vs. High Risk
Successful PCI
(n  2,104)
Failed PCI
(n  339)
p
Value
2.4 10.9 0.0001 0.0001
1.7 4.1 0.004 0.27
2.7 4.8 0.037 0.31
0.4 0.3 1.00 0.12
5.6 17.4 0.001 0.011
11 25 0.0001 0.0001
5.5 13 0.0001 0.0009
0.05 1.2 0.002 0.35
3.6 5.0 0.19 0.53
2.8 6.2 0.001 0.84
0.4 2.1 0.009 0.047
tion; MACE  major adverse cardiac events; MR  mitral regurgitation; PCI e
17
14
001
001
13
09
0
4
larizaate after the initial two to three days, whereas the group
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Discharge Strategy After Primary Angioplasty October 6, 2004:1400–7ith unsuccessful PCI continued to experience a higher rate
f death and MI up to 10 days.
A subgroup analysis of the clinical high-risk group showing
ifferent gradations of risk and 30-day outcome is given in
able 7. Patients with three or more high-risk clinical features
ad a significantly higher 30-day MACE than those with one
r two high-risk clinical features, which was primarily due to
igher mortality in the very high-risk group. Having three or
ore high-risk clinical features was also an independent
redictor of 30-day MACE (odds ratio [OR] 2.25, 95%
onfidence interval [CI] 1.62 to 3.12, p  0.0001) and death
OR 3.9, 95% CI 2.53 to 6.02, p  0.0001).
Further analysis to examine the timing of deaths in
atients who underwent successful PCI revealed a total of
8 deaths in the first 30 days of which 24 occurred by day
. Of the 34 patients who died between day 5 and day 30,
6 had three or more high-risk clinical features, and
nterestingly, 13 of these 16 patients had sustained
ypotension or congestive heart failure. Of the remaining
8 patients, the vast majority had cardiac or noncardiac
omplications that prolonged the hospital stay, and these
eaths occurred in the hospital. Only three patients died
f presumed cardiac causes after discharge from the
ospital on days 13, 20, and 19, and these patients had an
stimated LVEF of 30%, 35%, and 50%, respectively.
he last patient was recorded to have a re-infarction on
ay 12 requiring I-TVR.
able 6. Multivariate Predictors of One-Month Outcomes
OR 95% CI p Value
ACE
Unsuccessful PCI 3.50 2.58–4.73 0.0001
No stent 1.50 1.11–2.02 0.0081
Age 1.02 1.01–1.03 0.0001
Female gender 1.44 1.08–1.92 0.014
Multi-vessel disease 1.34 1.02–1.76 0.037
High clinical risk 1.13 0.79–1.60 0.51
eath
Unsuccessful PCI 4.35 2.82–6.71 0.0001
Age 1.07 1.05–1.09 0.0001
Multi-vessel disease 2.19 1.38–3.48 0.0008
Female gender 1.74 1.13–2.67 0.013
High clinical risk 2.36 0.99–5.63 0.052
able 5. One-Month Outcomes (%)
Variables
Low Clinical Risk
Successful PCI
(n  668)
Failed PCI
(n  77) p Valu
eath 0.5 4.0 0.017
e-infarction 0.9 4.0 0.056
-TVR 4.1 18 0.000
troke 0 0 —
ACE 4.6 22 0.000
eath/re-infarction 1.4 7.9 0.002
eath/re-infarction/
disabling stroke
2.6 16 0.002
-TVR  ischemia-driven target vessel revascularization; MACE  major adverse cHbbreviations as in Table 4.ISCUSSION
lthough the advent of thrombolytic therapy in late
980s improved the overall outcome of AMI patients,
ecurrent ischemic events continued to occur unpredict-
bly in the post-MI period, necessitating prolonged
bservation and additional testing. Thus, the latest na-
ional guidelines still recommend four to six days of
n-hospital observation of AMI patients, followed by
ome form of noninvasive testing for adequate risk
tratification (1). Primary PCI, on the other hand, is
ssociated with a low incidence of recurrent ischemic
vents (4,8,13) and allows adequate risk stratification of
MI patients at the time of initial angiography. The
AMI-II investigators have shown that the low-risk
ubsets of AMI patients undergoing successful primary
CI can be safely discharged from the hospital on day 3
2).
What defines “low risk,” however, is less clear. Is it the
linical risk status or the angiographic success? It is not
ncommon to encounter patients with angiographic success
nd “high-risk” clinical feature(s) or those with unsatisfac-
ory angiographic results in a clinically “low-risk” patient.
ur study shows that the angiographic result is the prime
eterminant of clinical outcome. In fact, patients undergo-
ng successful PCI had very few events after day 4, irrespec-
ive of their clinical risk status. It was only when three or
ore high-risk features were present concurrently that the
utcome was less satisfactory. Based on these findings, we
hink, the majority of AMI patients with 3 high-risk
linical features who undergo successful PCI may be dis-
harged from the hospital early, possibly by day 4. The
conomic impact of using PCI success as a major criterion
or discharge planning is huge, as five of every six patients
ndergoing primary PCI fulfilled the criteria for successful
CI.
As expected, in this study, the patients with high-risk
linical features and unsuccessful PCI had a significant
umber of MACE during the first post-MI month. This
bservation supports the current practice of keeping such
atients in the hospital for a longer observation period.
High Clinical Risk
p Value Low
vs. High Risk
Successful PCI
(n  2,104)
Failed PCI
(n  339) p Value
2.6 11 0.0001 0.0001
2 5 0.0002 0.041
4 6.5 0.019 0.11
0.6 1.1 0.35 0.23
7 21 0.0001 0.020
4.4 16 0.0001 0.0001
7 27 0.0001 0.0015
events; PCI  percutaneous coronary intervention.e
1
1owever, the immediate post-MI course of the clinically
l
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October 6, 2004:1400–7 Discharge Strategy After Primary Angioplastyow-risk group with unsuccessful PCI is less well known,
owever. The present study, for the first time, shows that
his subset of AMI patients is not at “low risk,” contrary to
eing classified clinically as being low risk. Hard end points
uch as death and re-infarction continue to occur well
eyond the initial 4 days, mandating an additional hospital
tay for these “low-risk” patients.
High-risk clinical features chosen in this study have
een shown to be the best independent predictors of
0-day outcome after AMI (12). However, this study
hows that the presence of one or two high-risk clinical
eatures does not negatively affect 30-day outcome in
MI patients undergoing successful PCI. In contrast, the
resence of three or more high-risk clinical features
ramatically increases the risk of an adverse outcome
uring the first post-MI month. The difference in 30-day
utcome between patients with two and three clinical
igh-risk features is statistically highly significant. In this
tudy, three or more high-risk clinical features were
resent in 13% of the study population. This small group
f highest risk patients is at a substantial risk of adverse
igure 1. Kaplan-Meier event-free survival rates for the composite end p
atients with successful percutaneous coronary intervention (PCI) had a lo
nsuccessful PCI continued to experience a significantly higher rate of maFigure 2. Kaplan-Meier event-free survival rates for the composite end pointardiovascular outcome, regardless of PCI success, and
ay merit longer observation and in-patient treatment.
The criteria used in the classification of high- and
ow-risk patients in this study are crucial. We used the
ame clinical high-risk features used in the Air-PAMI
tudy (10), which have been previously shown to be the
ost important predictors of early outcome after AMI
12). In an analysis of 41,021 AMI patients enrolled in
he GUSTO-1 study, advanced age, anterior infarction,
ower systolic pressure, higher Killip class, and elevated
eart rate were found to be the strongest predictors of
0-day mortality, and together, these five characteristics
ccounted for 90% of the prognostic information in the
aseline clinical data (12).
As the clinical high-risk group had older patients by
efinition, it is not surprising to find significant differ-
nces in the distribution of other baseline characteristics
etween the clinical high- and low-risk groups (Table 1).
owever, based on the GUSTO-1 observations already
entioned, the differences in the distribution of “other”
aseline variables between high and low clinical risk
of death, re-infarction, or ischemia-driven target vessel revascularization.
jor adverse cardiac events rate after hospital day 4, whereas patients with
verse cardiac events up to 7 to 10 days.oint
w maof death and re-infarction. PCI  percutaneous coronary intervention.
g
o
b
o
d
P
f
s
d
h
a
c
a
a
p
s
a
d
p
c
i
t
a
m
b
r
m
o
s
s
o
S
d
i
fl
w
t
d
s
i
p
e
f
c
t
c
t
c
e
t
t
p
C
c
t rate
T
A
1406 Heggunje et al. JACC Vol. 44, No. 7, 2004
Discharge Strategy After Primary Angioplasty October 6, 2004:1400–7roups would explain only a 10% difference in 30-day
utcome between the groups. Although some of the
aseline variables may have predicted procedural success,
n multivariate analysis, only female gender indepen-
ently predicted 30-day outcome.
The findings of the mortality analysis in the successful
CI group are consistent with an early discharge strategy
or AMI patients undergoing successful PCI. Only a very
mall number of deaths will be missed by a day 4
ischarge strategy for AMI patients with less than three
igh-risk clinical features who undergo successful PCI
nd do not have any overt cardiac or noncardiac compli-
ations. Some of these deaths are likely to be arrhythmic
nd may need specialized electrophysiologic evaluation
nd/or treatment rather than a prolonged hospital stay to
revent them. Temporary use of external defibrillators in
elected patients with a low LVEF is one such consider-
tion and needs further evaluation in this setting.
The finding of PCI success as the most important
eterminant of adverse cardiac events during the first
ost-MI month is not surprising. Both experimental and
linical evidence indicates that the benefits of a patent
nfarct-related artery include a favorable effect on ven-
ricular remodeling (improved healing of infarcted tissue
nd prevention of infarct expansion) (14,15), improve-
ent in left ventricular diastolic and systolic function,
etter electrical stability, and reduced long-term recur-
ent ischemic events and mortality (16,17). We used a
Figure 3. Kaplan-Meier analysis of the cumulative even
able 7. Different Gradations of Clinical Risk and 30-Day Outco
Number of High-
Risk Features
Number of
Patients Death
1 1,359 30 (2.2%)
2 811 29 (3.6%)
3 331 30 (9.1%)
4 96 13 (13.5%)
5 16 1 (6.3%)
p value — 0.0001bbreviations as in Table 5.ore stringent definition of PCI success by including
nly TIMI flow grade III and also a final diameter
tenosis 30% instead of 50%. This definition of PCI
uccess probably contributed to better risk stratification
f AMI patients (18,19).
tudy limitations. This is a post-hoc analysis of pooled
ata from multiple clinical trials and is subject to the
nherent limitations of such analysis. Although TIMI
ow grade 3 in the infarct-related artery is associated
ith a good outcome, a few patients may do poorly due
o microvascular pathology. We did not include myocar-
ial blush score or TIMI frame count to define PCI
uccess. However, this is unlikely to influence the find-
ngs of this study, as once-month mortality in low-risk
atients with successful PCI was only 0.5%. We only
valuated MACE, but other problems such as heart
ailure and bradyarrhythmias, which may influence dis-
harge planning significantly, are not evaluated. Informa-
ion on medical treatment was incomplete and hence
ould not be analyzed. By design, PAMI studies excluded
he highest risk patients, such as those presenting with
ardiogenic shock, recent cerebrovascular accident or
nd-stage renal disease, and our data are not applicable to
his population. Finally, our data are applicable to pa-
ients undergoing primary PCI and may not apply to
atients undergoing rescue or delayed PCI.
onclusions. In patients undergoing primary PCI, pro-
edural success provides significant additional prognostic
for death. PCI  percutaneous coronary intervention.
Re-Infarction I-TVR MACE
31 (2.3%) 55 (4.6%) 96 (7.9%)
18 (2.2%) 23 (3.1%) 67 (8.9%)
13 (4.0%) 15 (5.4%) 51 (17.3%)
2 (2.1%) 1 (1.2%) 14 (16.3%)
1 (6.3%) 0 2 (13.3%)
0.35 0.20 0.0001mes
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October 6, 2004:1400–7 Discharge Strategy After Primary Angioplastyalue to the “clinical risk stratification” algorithm that
ould be useful in the discharge planning of such patients.
arring other complications such as heart failure, ar-
hythmia, or noncardiac complications, most patients
ith angiographically successful PCI can safely be dis-
harged from the hospital early, possibly by day 4. In
ontrast, patients with an angiographically suboptimal
utcome might need longer periods of hospitalization
nd remain at relatively high risk for MACE up to 7 to
0 days. Very high-risk patients with three or more
igh-risk clinical features may also need longer periods of
ospitalization, regardless of PCI outcome.
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